Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Berger JS, et al. Among authors: roncaglioni mc. JAMA. 2006 Jan 18;295(3):306-13. doi: 10.1001/jama.295.3.306. JAMA. 2006. PMID: 16418466
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A; PPP Collaborative Group. Sacco M, et al. Among authors: roncaglioni mc. Diabetes Care. 2003 Dec;26(12):3264-72. doi: 10.2337/diacare.26.12.3264. Diabetes Care. 2003. PMID: 14633812 Clinical Trial.
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Antithrombotic Trialists' (ATT) Collaboration, et al. Among authors: roncaglioni mc. Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1. Lancet. 2009. PMID: 19482214 Free PMC article.
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.
Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z, Meade TW. Rothwell PM, et al. Among authors: roncaglioni mc. Lancet. 2012 Apr 28;379(9826):1602-12. doi: 10.1016/S0140-6736(11)61720-0. Epub 2012 Mar 21. Lancet. 2012. PMID: 22440946 Review.
Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study.
Marzona I, Avanzini F, Lucisano G, Tettamanti M, Baviera M, Nicolucci A, Roncaglioni MC; Risk & Prevention Collaborative Group. Marzona I, et al. Among authors: roncaglioni mc. Acta Diabetol. 2017 Feb;54(2):123-131. doi: 10.1007/s00592-016-0899-0. Epub 2016 Oct 7. Acta Diabetol. 2017. PMID: 27718051
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012.
Baviera M, Avanzini F, Marzona I, Tettamanti M, Vannini T, Cortesi L, Fortino I, Bortolotti A, Merlino L, Trevisan R, Roncaglioni MC. Baviera M, et al. Among authors: roncaglioni mc. Nutr Metab Cardiovasc Dis. 2017 Jan;27(1):54-62. doi: 10.1016/j.numecd.2016.10.006. Epub 2016 Oct 24. Nutr Metab Cardiovasc Dis. 2017. PMID: 27956023
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
Rothwell PM, Cook NR, Gaziano JM, Price JF, Belch JFF, Roncaglioni MC, Morimoto T, Mehta Z. Rothwell PM, et al. Among authors: roncaglioni mc. Lancet. 2018 Aug 4;392(10145):387-399. doi: 10.1016/S0140-6736(18)31133-4. Epub 2018 Jul 17. Lancet. 2018. PMID: 30017552 Free PMC article.
Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.
Marzona I, Proietti M, Farcomeni A, Romiti GF, Romanazzi I, Raparelli V, Basili S, Lip GYH, Nobili A, Roncaglioni MC. Marzona I, et al. Among authors: roncaglioni mc. Int J Cardiol. 2018 Oct 15;269:182-191. doi: 10.1016/j.ijcard.2018.07.044. Epub 2018 Jul 9. Int J Cardiol. 2018. PMID: 30025657
Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?
Monesi L, Avanzini F, Barlera S, Caimi V, Lauri D, Longoni P, Roccatagliata D, Tombesi M, Tognoni G, Roncaglioni MC. Monesi L, et al. Among authors: roncaglioni mc. Eur J Clin Pharmacol. 2005 Sep;61(8):595-601. doi: 10.1007/s00228-005-0948-z. Epub 2005 Jul 15. Eur J Clin Pharmacol. 2005. PMID: 16021439
The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives.
Sanz G, Fuster V, Guzmán L, Guglietta A, Arnáiz JA, Martínez F, Sarria A, Roncaglioni MC, Taubert K. Sanz G, et al. Among authors: roncaglioni mc. Am Heart J. 2011 Nov;162(5):811-817.e1. doi: 10.1016/j.ahj.2011.08.012. Am Heart J. 2011. PMID: 22093195 Clinical Trial.
84 results
Jump to page
Feedback